ProPhase Labs, Inc. (PRPH)

ProPhase Labs Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	44.38	122.65	79.04	14.51	9.88
Revenue Growth (YoY)	-63.81%	55.17%	444.59%	46.96%	-24.76%
Cost of Revenue	28.15	51.99	37.05	9.91	7.26
Gross Profit	16.24	70.65	41.99	4.61	2.62
Selling, General & Admin	34.5	34.39	22.49	7.5	5.52
Research & Development	1.42	0.65	0.52	0.63	0.33
Other Operating Expenses	1.93	12.02	9.17	0.45	0
Operating Expenses	37.85	47.06	32.19	8.58	5.85
Operating Income	-21.61	23.6	9.8	-3.97	-3.24
Interest Expense / Income	1.28	0.76	1.15	0.3	0
Other Expense / Income	-0.09	-0.08	3.35	-2.16	-0.09
Pretax Income	-22.8	22.91	5.31	-2.11	-3.15
Income Tax	-6.02	4.45	-0.97	0.01	0
Net Income	-16.78	18.46	6.27	-2.13	-3.15
Net Income Growth	-	194.32%	-	-	-
Shares Outstanding (Basic)	17	16	15	12	12
Shares Outstanding (Diluted)	17	19	18	12	12
Shares Change	-7.74%	1.40%	58.63%	0.27%	1.47%
EPS (Basic)	-0.98	1.17	0.41	-0.18	-0.27
EPS (Diluted)	-0.98	1.02	0.40	-0.18	-0.27
EPS Growth	-	155.00%	-	-	-
Free Cash Flow	-14.46	25.08	-17.85	-2.2	-1.07
Free Cash Flow Per Share	-0.84	1.58	-1.18	-0.19	-0.09
Dividend Per Share	-	0.600	0.300	-	0.500
Dividend Growth	-	100.00%	-	-	-50.00%
Gross Margin	36.59%	57.61%	53.12%	31.73%	26.48%
Operating Margin	-48.70%	19.24%	12.40%	-27.37%	-32.80%
Profit Margin	-37.81%	15.05%	7.94%	-14.64%	-31.86%
Free Cash Flow Margin	-32.57%	20.45%	-22.58%	-15.16%	-10.82%
Effective Tax Rate	-	19.40%	-18.25%	-	-
EBITDA	-14.83	28.73	10.02	-1.36	-2.75
EBITDA Margin	-33.41%	23.43%	12.67%	-9.37%	-27.83%
Depreciation & Amortization	6.7	5.06	3.56	0.46	0.4
EBIT	-21.53	23.67	6.45	-1.82	-3.15
EBIT Margin	-48.50%	19.30%	8.16%	-12.53%	-31.86%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).